# LakeShore Biopharma Co. Ltd (LSB)

Source: https://www.quantisnow.com/company/LSB
Generated: 2026-11-10T00:16:38.530Z

- Ticker: LSB
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations

## Latest LSB news and filings

- 2025-11-14 18:25 UTC [SEC Form 25-NSE filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-lakeshore-biopharma-co-ltd-6279910)
- 2025-11-04 12:13 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-6257961)
- 2025-09-22 12:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-6207543)
- 2025-09-22 12:00 UTC [LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting](https://www.quantisnow.com/insight/lakeshore-biopharma-announces-transition-to-otc-market-following-nasdaq-delisting-6207518)
- 2025-09-12 13:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-6198924)
- 2025-09-12 12:00 UTC [LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq](https://www.quantisnow.com/insight/lakeshore-biopharma-announces-receipt-of-delisting-determination-letter-from-nasdaq-6198835)
- 2025-09-10 12:58 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-6196057)
- 2025-09-10 12:10 UTC [Leadership Update] [LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee](https://www.quantisnow.com/insight/lakeshore-biopharma-announces-appointment-of-independent-financial-advisor-and-legal-6195969)
- 2025-08-28 12:34 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-6181886)
- 2025-08-28 12:00 UTC [LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee](https://www.quantisnow.com/insight/lakeshore-biopharma-announces-receipt-of-a-revised-preliminary-non-binding-proposal-6181799)
- 2025-08-18 12:36 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-6169449)
- 2025-08-18 12:00 UTC [LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company](https://www.quantisnow.com/insight/lakeshore-biopharma-announces-receipt-of-a-preliminary-non-binding-proposal-to-6169366)
- 2025-07-31 18:55 UTC [Earnings] [LakeShore Biopharma Announces Fiscal Year 2025 Financial Results](https://www.quantisnow.com/insight/lakeshore-biopharma-announces-fiscal-year-2025-financial-results-6140714)
- 2025-07-31 18:39 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-6140702)
- 2025-07-31 18:38 UTC [SEC Form 20-F filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-20-f-filed-by-lakeshore-biopharma-co-ltd-6140701)
- 2025-07-15 20:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-6120529)
- 2025-07-08 12:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-6113581)
- 2025-07-08 11:25 UTC [LakeShore Biopharma Announces US$15 Million Private Placement Financing](https://www.quantisnow.com/insight/lakeshore-biopharma-announces-us15-million-private-placement-financing-6113441)
- 2025-05-12 10:50 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-6031570)
- 2025-05-06 10:45 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-6019547)
- 2025-04-23 13:35 UTC [LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell)](https://www.quantisnow.com/insight/lakeshore-biopharma-announces-the-official-launch-of-a-novel-packaging-5997688)
- 2025-03-25 10:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-5958487)
- 2025-03-14 13:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-lakeshore-biopharma-co-ltd-5944539)
- 2025-03-12 13:19 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-5940189)
- 2024-12-19 14:28 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-5820119)
- 2024-12-19 14:05 UTC [Earnings] [LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance](https://www.quantisnow.com/insight/lakeshore-biopharma-reports-unaudited-financial-results-for-the-first-half-5820091)
- 2024-12-13 00:57 UTC [LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China](https://www.quantisnow.com/insight/lakeshore-biopharma-provides-update-on-ongoing-criminal-investigation-involving-former-5812003)
- 2024-12-12 21:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-5811217)
- 2024-11-12 13:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-5765343)
- 2024-11-07 13:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-5757864)
- 2024-11-07 13:00 UTC [LakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of Pakistan](https://www.quantisnow.com/insight/lakeshore-biopharma-initiates-biologics-license-application-of-pika-rabies-vaccine-5757724)
- 2024-11-01 20:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-5748154)
- 2024-10-29 13:16 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-5741217)
- 2024-10-29 12:30 UTC [LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement](https://www.quantisnow.com/insight/lakeshore-biopharma-regains-compliance-with-nasdaq-minimum-bid-price-requirement-5741097)
- 2024-10-25 12:40 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-5738181)
- 2024-10-25 12:30 UTC [LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine](https://www.quantisnow.com/insight/lakeshore-biopharma-granted-phase-iii-clinical-trial-approval-to-explore-5738160)
- 2024-10-08 12:59 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-5719340)
- 2024-10-08 12:30 UTC [LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance](https://www.quantisnow.com/insight/lakeshore-biopharma-provides-fiscal-half-year-2025-financial-guidance-and-5719268)
- 2024-09-27 11:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by LakeShore Biopharma Co. Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakeshore-biopharma-co-ltd-5706574)
- 2024-09-27 11:00 UTC [Earnings Date] [LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation](https://www.quantisnow.com/insight/lakeshore-biopharma-announces-results-of-extraordinary-general-meeting-on-share-5706564)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/LSB
- Earnings history: https://www.quantisnow.com/earnings/LSB
- Dividend history: https://www.quantisnow.com/dividends/LSB
- Insider transactions: https://www.quantisnow.com/insiders/LSB
- Options chain: https://www.quantisnow.com/options/LSB
- SEC 8-K filings only: https://www.quantisnow.com/company/LSB/8-k
- RSS and alerts for LSB: https://www.quantisnow.com/docs/rss-feeds.md